We are live on
!
Find out more
Lantern Pharma
LTRN
LTRN
33 hedge funds and large institutions have $2.87M invested in Lantern Pharma in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.64% less ownership
Funds ownership: 20.39% → 18.75% (-1.6%)
58% less capital invested
Capital invested by funds: $6.91M → $2.87M (-$4.04M)
Holders
33
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$69.9K | |
| 2 | +$41.7K | |
| 3 | +$39.6K | |
| 4 |
Renaissance Technologies
New York
|
+$15.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.63K |
Top Sellers
| 1 | -$406K | |
| 2 | -$99.7K | |
| 3 | -$87.3K | |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$29.8K |
| 5 |
Bank of New York Mellon
New York
|
-$14.5K |
